The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Kemble George | Director | Option exercise(M) | 24K | — | $0 |
| Aug 14, 2026 | Kemble George | Director | Option exercise(M) | 327K | — | $0 |
| Aug 14, 2026 | Kemble George | Director | Sell(S) | 351K | $10.23 | $3.6M |
| Aug 14, 2026 | Kemble George | Director | Option exercise(M) | 24K | $6.36 | $155K |
| Aug 14, 2026 | Kemble George | Director | Option exercise(M) | 327K | $6.36 | $2.1M |
| Aug 11, 2026 | Kemble George | Director | Option exercise(M) | 10K | — | $0 |
| Aug 11, 2026 | Kemble George | Director | Option exercise(M) | 10K | — | $0 |
| Aug 11, 2026 | Kemble George | Director | Sell(S) | 20K | $9.95 | $201K |
| Aug 11, 2026 | Kemble George | Director | Option exercise(M) | 10K | $6.36 | $66K |
| Aug 11, 2026 | Kemble George | Director | Option exercise(M) | 10K | $6.36 | $62K |
| Jul 20, 2026 | Happel David | President & CEO, Director | Sell(S) | 64K | $7.76 | $497K |
| Jul 20, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Sell(S) | 11K | $7.76 | $82K |
| Jul 20, 2026 | Kemble George | Director | Sell(S) | 19K | $7.46 | $141K |
| Jun 12, 2026 | Seidenberg Beth C | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2026 | Hoelscher Paul W. | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2026 | Jarrett Jennifer | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2026 | Grammer Elizabeth A | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2026 | Kemble George | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2026 | Phillips Anne M. | Director | Grant(A) | 40K | — | $0 |
| May 28, 2026 | Happel David | President & CEO, Director | Grant(A) | 300K | — | $0 |
| May 28, 2026 | Grauer Andreas | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| May 28, 2026 | Chauche Thierry | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| May 28, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Grant(A) | 100K | — | $0 |
| Apr 20, 2026 | Grauer Andreas | Chief Medical Officer | Grant(A) | 265K | — | $0 |
| Feb 19, 2026 | Chauche Thierry | Chief Financial Officer | Grant(A) | 44K | — | $0 |
| Feb 19, 2026 | Chauche Thierry | Chief Financial Officer | Grant(A) | 88K | — | $0 |
| Feb 19, 2026 | Happel David | President & CEO, Director | Grant(A) | 128K | — | $0 |
| Feb 19, 2026 | Happel David | President & CEO, Director | Grant(A) | 256K | — | $0 |
| Feb 19, 2026 | Martins Eduardo Bruno | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Feb 19, 2026 | Martins Eduardo Bruno | Chief Medical Officer | Grant(A) | 88K | — | $0 |
| Feb 19, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Grant(A) | 44K | — | $0 |
| Feb 19, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Grant(A) | 88K | — | $0 |
| Feb 10, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Sell(S) | 3K | $5.36 | $14K |
| Feb 10, 2026 | Martins Eduardo Bruno | Chief Medical Officer | Sell(S) | 4K | $5.36 | $20K |
| Feb 10, 2026 | Chauche Thierry | Chief Financial Officer | Sell(S) | 1K | $5.36 | $7K |
| Feb 10, 2026 | Happel David | President & CEO, Director | Sell(S) | 12K | $5.36 | $65K |
| Nov 20, 2025 | Kemble George | Executive Chairman, Director | Sell(S) | 38K | $7.69 | $290K |
| Nov 4, 2025 | Rozek Elizabeth | Chief Legal & Admin. Officer | Grant(A) | 10K | — | $0 |
| Nov 4, 2025 | Rozek Elizabeth | Chief Legal & Admin. Officer | Grant(A) | 13K | — | $0 |
| Jul 21, 2025 | Rozek Elizabeth | General Counsel and CCO | Sell(S) | 11K | $9.13 | $98K |
| Jul 21, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Sell(S) | 8K | $9.13 | $76K |
| Jul 21, 2025 | Happel David | President & CEO, Director | Sell(S) | 65K | $9.13 | $598K |
| Jun 9, 2025 | Grammer Elizabeth A | Director | Grant(A) | 32K | — | $0 |
| Jun 9, 2025 | Hoelscher Paul W. | Director | Grant(A) | 32K | — | $0 |
| Jun 9, 2025 | Jarrett Jennifer | Director | Grant(A) | 27K | — | $0 |
| Jun 9, 2025 | Kemble George | Director | Grant(A) | 32K | — | $0 |
| Jun 9, 2025 | Phillips Anne M. | Director | Grant(A) | 27K | — | $0 |
| Jun 9, 2025 | Seidenberg Beth C | Director | Grant(A) | 32K | — | $0 |
| Jun 9, 2025 | Walbert Timothy P | Director | Grant(A) | 32K | — | $0 |
| Jun 6, 2025 | Seidenberg Beth C | Director | Grant(A) | 29K | — | $0 |
| Feb 6, 2025 | Happel David | President & CEO, Director | Grant(A) | 472K | — | $0 |
| Feb 6, 2025 | Chauche Thierry | Chief Financial Officer | Grant(A) | 17K | — | $0 |
| Feb 6, 2025 | Chauche Thierry | Chief Financial Officer | Grant(A) | 69K | — | $0 |
| Feb 6, 2025 | Rozek Elizabeth | General Counsel and CCO | Grant(A) | 34K | — | $0 |
| Feb 6, 2025 | Rozek Elizabeth | General Counsel and CCO | Grant(A) | 138K | — | $0 |
| Feb 6, 2025 | Happel David | President & CEO, Director | Grant(A) | 116K | — | $0 |
| Feb 6, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Grant(A) | 34K | — | $0 |
| Feb 6, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Grant(A) | 138K | — | $0 |
| Aug 1, 2024 | Phillips Anne M. | Director | Grant(A) | 114K | — | $0 |
| Aug 1, 2024 | Jarrett Jennifer | Director | Grant(A) | 114K | — | $0 |
| Jul 23, 2024 | Kemble George | Executive Chairman, Director | Sell(S) | 24K | $3.17 | $75K |
| Jul 19, 2024 | Kemble George | Executive Chairman, Director | Sell(S) | 14K | $3.10 | $44K |
| Jul 19, 2024 | Rozek Elizabeth | General Counsel and CCO | Sell(S) | 11K | $3.10 | $34K |
| Jul 19, 2024 | Martins Eduardo Bruno | Chief Medical Officer | Sell(S) | 8K | $3.10 | $26K |
| Jun 5, 2024 | Grammer Elizabeth A | Director | Grant(A) | 51K | — | $0 |
| Jun 5, 2024 | Hoelscher Paul W. | Director | Grant(A) | 9K | — | $0 |
| Jun 5, 2024 | Parsey Merdad | Director | Grant(A) | 51K | — | $0 |
| Jun 5, 2024 | Seidenberg Beth C | Director | Grant(A) | 51K | — | $0 |
| Jun 5, 2024 | Walbert Timothy P | Director | Grant(A) | 9K | — | $0 |
| May 6, 2024 | Chauche Thierry | Chief Financial Officer | Grant(A) | 587K | — | $0 |
| Apr 1, 2024 | Hoelscher Paul W. | Director | Grant(A) | 73K | — | $0 |
| Apr 1, 2024 | Walbert Timothy P | Director | Grant(A) | 73K | — | $0 |
| Mar 26, 2024 | Happel David | President & CEO, Director | Buy(P) | 12K | $5.27 | $64K |
| Jan 29, 2024 | New Enterprise Associates 13 LP | 10% Owner | Other(J) | 850K | — | $0 |
| Jan 29, 2024 | Nea 13 GP, Ltd | 10% Owner | Other(J) | 850K | — | $0 |
| Jan 29, 2024 | Nea 13 GP, Ltd | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Nea 13 GP, Ltd | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Baskett Forest | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Baskett Forest | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Baskett Forest | 10% Owner | Other(J) | 11K | — | $0 |
| Jan 29, 2024 | Baskett Forest | 10% Owner | Other(J) | 850K | — | $0 |
| Jan 29, 2024 | Kerins Patrick J | 10% Owner | Other(J) | 13K | — | $0 |
| Jan 29, 2024 | Kerins Patrick J | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Kerins Patrick J | 10% Owner | Other(J) | 850K | — | $0 |
| Jan 29, 2024 | Kerins Patrick J | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Sandell Scott D | 10% Owner | Other(J) | 261K | — | $0 |
| Jan 29, 2024 | Sandell Scott D | 10% Owner | Other(J) | 7K | — | $0 |
| Jan 29, 2024 | Sandell Scott D | 10% Owner | Other(J) | 850K | — | $0 |
| Jan 29, 2024 | Sandell Scott D | 10% Owner | Other(J) | 261K | — | $0 |
| Dec 7, 2023 | Happel David | President & CEO, Director | Buy(P) | 2K | $4.10 | $7K |
| Nov 17, 2023 | Happel David | President & CEO, Director | Grant(A) | 625K | — | $0 |
| Nov 17, 2023 | Kemble George | Executive Chairman, Director | Grant(A) | 151K | — | $0 |
| Nov 17, 2023 | Martins Eduardo Bruno | Chief Medical Officer | Grant(A) | 90K | — | $0 |
| Nov 17, 2023 | Rozek Elizabeth | General Counsel and CCO | Grant(A) | 171K | — | $0 |
| Nov 16, 2023 | Happel David | President & CEO, Director | Buy(P) | 590 | $2.35 | $1K |
| Sep 7, 2023 | Kemble George | Executive Chairman, Director | Option exercise(M) | 6K | $0.79 | $4K |
| Sep 7, 2023 | Kemble George | Executive Chairman, Director | Option exercise(M) | 6K | — | $0 |
| Jul 18, 2023 | Grammer Elizabeth A | Director | Disposed to issuer(D) | 50K | — | $0 |
| Jul 18, 2023 | Grammer Elizabeth A | Director | Grant(A) | 50K | — | $0 |
| Jul 18, 2023 | Happel David | President & CEO, Director | Disposed to issuer(D) | 1.0M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Sagimet Biosciences Inc., SEC CIK 0001400118. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SGMT and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SGMT